Pfizer Hit With $38 Million Verdict for Stealing Trade Secrets
Posted on Jan 07, 2009
On December 22, a California jury found that Pfizer improperly obtained tons of medical research from the non-profit Ischemia Research and Education Foundation, which it then used in its clinical trials of its product, Bextra. In interviews after the verdict was rendered, the foreperson noted that there was overwhelming evidence that Pfizer had secretly conspired with one of the Foundation's employees to obtain the Foundation's data without paying for it. Although the jury's verdict was for $38 million, the Court has still yet to decide the amount of punitive damages that will be assessed against Pfizer, which could triple that amount.